Heart failure with preserved ejection fraction (HFpEF) affects millions and carries high hospitalization and mortality rates. Often driven by comorbidities like hypertension, obesity and diabetes, it can present with clear congestion or unexplained exertional dyspnea. Learn how emerging diagnostics and therapies (including SGLT2 inhibitors, lifestyle changes, and targeted management) are reshaping care.